CompletedNot applicableNCT04343521

Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases

Studying Chikungunya

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emory University
Principal Investigator
Gonzalo Vazquez Prokopec, MD
Emory University
Intervention
Targeted Indoor Residual Spraying (TIRS)(other)
Enrollment
4461 enrolled
Eligibility
2-15 years · All sexes
Timeline
2020 – 2024

Study locations (1)

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04343521 on ClinicalTrials.gov

Other trials for Chikungunya

Additional recruiting or active studies for the same condition.

See all trials for Chikungunya →

← Back to all trials